175 related articles for article (PubMed ID: 31072504)
1. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document.
Spitzer E; McFadden E; Vranckx P; Garcia-Garcia HM; Seltzer JH; Held C; de Vries T; Menon V; Brown KJ; Soliman OII; Onuma Y; Lopes RD; Stone GW; Cutlip DE; Serruys PW
JACC Cardiovasc Interv; 2019 May; 12(9):805-819. PubMed ID: 31072504
[TBL] [Abstract][Full Text] [Related]
2. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
[TBL] [Abstract][Full Text] [Related]
3. Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials.
Wessler JD; Généreux P; Mehran R; Ayele GM; Brener SJ; McEntegart M; Ben-Yehuda O; Stone GW; Kirtane AJ
JACC Cardiovasc Interv; 2016 Feb; 9(4):331-337. PubMed ID: 26803422
[TBL] [Abstract][Full Text] [Related]
4. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
5. Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.
Idris H; Lo S; Shugman IM; Saad Y; Hopkins AP; Mussap C; Leung D; Thomas L; Juergens CP; French JK
J Am Heart Assoc; 2014 Oct; 3(6):e001086. PubMed ID: 25359403
[TBL] [Abstract][Full Text] [Related]
6. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
7. Clinical Endpoints and Key Data Elements in Percutaneous Coronary Intervention of Coronary Chronic Total Occlusion Studies: A Call to the Academic Research Consortium for Standardized Definitions.
Ybarra LF; Piazza N; Brilakis E; Grantham JA; Stone GW; Rinfret S
JACC Cardiovasc Interv; 2017 Nov; 10(21):2185-2187. PubMed ID: 29122132
[No Abstract] [Full Text] [Related]
8. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
9. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
[TBL] [Abstract][Full Text] [Related]
10. Frequency and impact of bleeding in elective coronary stent clinical trials--utility of three commonly used definitions.
Fleming LM; Novack V; Novack L; Cohen SA; Negoita M; Cutlip DE
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E23-9. PubMed ID: 22109802
[TBL] [Abstract][Full Text] [Related]
11. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
[TBL] [Abstract][Full Text] [Related]
12. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
[TBL] [Abstract][Full Text] [Related]
13. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Brener SJ; Cristea E; Kirtane AJ; McEntegart MB; Xu K; Mehran R; Stone GW
JACC Cardiovasc Interv; 2013 Jan; 6(1):36-43. PubMed ID: 23266233
[TBL] [Abstract][Full Text] [Related]
14. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
15. Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.
Taniwaki M; Stefanini GG; Räber L; Brugaletta S; Cequier A; Heg D; Iñiguez A; Kelbæk H; Serra A; Ostoijic M; Hernandez-Antolin R; Baumbach A; Blöchlinger S; Jüni P; Mainar V; Sabate M; Windecker S
EuroIntervention; 2015 Aug; 11(4):391-8. PubMed ID: 25042419
[TBL] [Abstract][Full Text] [Related]
16. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.
Spitzer E; de Vries T; Cavalcante R; Tuinman M; Rademaker-Havinga T; Alkema M; Morel MA; Soliman OI; Onuma Y; van Es GA; Tijssen JGP; McFadden E; Serruys PW
JACC Cardiovasc Interv; 2017 Apr; 10(7):658-666. PubMed ID: 28385402
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stents for ST-elevation myocardial infarction: ready for prime time?
Lee CW; Park SJ
Coron Artery Dis; 2014 Aug; 25(5):365-6. PubMed ID: 24984243
[No Abstract] [Full Text] [Related]
18. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
[TBL] [Abstract][Full Text] [Related]
20. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
Wang H; Liang Z; Li Y; Li B; Liu J; Hong X; Lu X; Wu J; Zhao W; Liu Q; An J; Li L; Pu F; Ming Q; Han Y
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28083915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
